Friday, July 10, 2026

Drug profile · INN

benazepril

benazepril is a angiotensin-converting enzyme inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — benazepril
Class
Route
Patents
0
Programs
5
Data quality
0.70

Quick answer

benazepril is a angiotensin-converting enzyme inhibitor.

Key facts

INN benazepril
Mechanism Angiotensin-converting enzyme inhibitor

Mechanism of action

Angiotensin-converting enzyme inhibitor

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. CXXB750A12201 Phase 2 · Novartis India · Heart Failure
  2. Amlodipine-benazepril 10 mg-20 mg capsules Phase 1 · Teva Pharma · Healthy
  3. Benazepril HCl 40 mg Tablets Phase 1 · Teva Pharma · Healthy
  4. Benazepril Unknown · Sun Yat-sen University · Renal Function Disorder
  5. Benazepril Unknown · Chinese Academy of · Renal Insufficiency,Chronic

Frequently asked questions

What is benazepril?

benazepril is a angiotensin-converting enzyme inhibitor.